G01N2800/065 - page 2 - CPC Classification Index

#301

20160334401

2016-11-17

Methods for predicting post-operative recurrence of Crohn's disease

#302

20160333100

2016-11-17

CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT

#303

20160312290

2016-10-27

Use and identification of biomarkers for gastrointestinal diseases

#304

20160299152

2016-10-13

Method for detecting nucleosomes containing histone variants

#305

20160280785

2016-09-29

Compositions and methods for diagnosing and treating an inflammation

#306

20160266147

2016-09-15

Method for diagnosing inflammatory bowel disease

#307

20160252533

2016-09-01

Diagnosis and treatment of autoimmune diseases

#308

20160245804

2016-08-25

Methods, Systems and Kits of Fecal NGal Rapid Immunochromatographic Test

#309

20160244836

2016-08-25

Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof

#310

20160215046

2016-07-28

Signature of TL1A (TNFSF15) signaling pathway

#311

20160209426

2016-07-21

USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS

#312

20160193288

2016-07-07

Therapeutic TREM-1 peptides

#313

20160178644

2016-06-23

METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE

#314

20160161503

2016-06-09

Diagnostic method for inflammatory bowel disease

#315

20160161501

2016-06-09

Inflammatory bowel disease markers and therapies for colitis-associated intestinal fibrosis

#316

20160145306

2016-05-26

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

#317

20160139148

2016-05-19

Pathway specific markers for diagnosing irritable bowel syndrome

#318

20160130279

2016-05-12

Pathway specific assays for predicting irritable bowel syndrome diagnosis

#319

20160109444

2016-04-21

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF CROHN'S DISEASE

#320

20160103136

2016-04-14

Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease

#321

20160091501

2016-03-31

METHOD FOR DIAGNOSING AND TREATING CROHN'S DISEASE

#322

20160091491

2016-03-31

METHODS FOR DIAGNOSIS OF CELIAC DISEASE

#323

20160084846

2016-03-24

Methods and compositions for determining and treating relapse in inflammatory bowel disease

#324

20160077107

2016-03-17

PERSONALISED MEDICINE

#325

20160061837

2016-03-03

Antibody to cytolethal distending toxin of Campylobacter jejuni

#326

20160061832

2016-03-03

Biomarkers for inflammatory bowel disease with ankylosing spondylitis

#327

20160061825

2016-03-03

Kits for Fecal Neopterin Concentration Measurement as an Indicator of Disease Activity in Inflammatory Bowel Disease

#328

20160060335

2016-03-03

Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway

#329

20160041148

2016-02-11

PLACEBO-CONTROLLED GLUTEN CHALLENGE METHOD

#330

20160032363

2016-02-04

Methods for the diagnosis and treatment of inflammatory bowel disease

#331

20160032013

2016-02-04

Method of reducing blood glucose by administering RON agonists

#332

20160011209

2016-01-14

Application of N-terminomics to NETosis in inflammation

#333

20150376696

2015-12-31

Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease

#334

20150362493

2015-12-17

Methods of determining levels of cleaved and/or intact kininogen

#335

20150355195

2015-12-10

METHODS FOR PREDICTING AND MONITORING MUCOSAL HEALING

#336

20150346200

2015-12-03

Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for IBS

#337

20150344569

2015-12-03

Compositions and methods for diagnosing and treating an inflammation

#338

20150323554

2015-11-12

Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and LC/MS/MS workflow

#339

20150323546

2015-11-12

Biomarkers in inflammatory bowel disease

#340

20150307611

2015-10-29

Methods for diagnosing and treating inflammatory bowel disease

#341

20150293123

2015-10-15

Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis

#342

20150293113

2015-10-15

Serological markers of inflammatory bowel disease phenotype and disease progression

#343

20150285815

2015-10-08

Methods for detecting antibodies

#344

20150274839

2015-10-01

Antibodies to non-functional P2X7 receptor

#345

20150259748

2015-09-17

Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease

#346

20150247850

2015-09-03

GP2 ISOFORMS AND THEIR USE IN AUTOANTIBODY CAPTURE

#347

20150233944

2015-08-20

Methods for detecting the presence of irritable bowel syndrome and system for diagnosing same

#348

20150232485

2015-08-20

Multi-sensor array compound and methods of use thereof

#349

20150218272

2015-08-06

Compositions and methods for diagnosing and treating an inflammation

#350

20150202329

2015-07-23

Methods and Composition for Detecting Intestinal Cell-Barrier Dysfunction

#351

20150166631

2015-06-18

ANTI-PRO87299 ANTIBODIES

#352

20150160210

2015-06-11

COMPOSITIONS AND METHODS FOR ASSESSING GASTROINTESTINAL HEALTH

#353

20150152470

2015-06-04

THE USE OF ENDOTOXIN NEUTRALIZATION AS A BIOMARKER FOR INTESTINAL WALL DAMAGE

#354

20150148245

2015-05-28

Methods of monitoring responsiveness to anti-SMAD7 therapy

#355

20150133330

2015-05-14

Methods and compositions useful for diagnosing inflammatory bowel disease-associated neoplasia

#356

20150119275

2015-04-30

Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis

#357

20150094272

2015-04-02

Treatments for gastrointestinal disorders

#358

20150079116

2015-03-19

Diagnostic tools for response to 6-thiopurine therapy

#359

20150072879

2015-03-12

METHODS FOR IMPROVING INFLAMMATORY BOWEL DISEASE DIAGNOSIS

#360

20150071917

2015-03-12

Methods and products for evaluating an immune response to a therapeutic protein

#361

20150010584

2015-01-08

Targeted Delivery Of Autoantigens To B Cell Populations

#362

20140378347

2014-12-25

Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease

#363

20140349956

2014-11-27

MATERIALS AND METHODS FOR DETECTING AND/OR PREDICTING NECROTIZING ENTEROCOLITIS IN INFANTS

#364

20140322209

2014-10-30

Administration of alpha4beta7 hetero-dimer-specific antibody

#365

20140255953

2014-09-11

Granzyme A and granzyme B diagnostics

#366

20140220014

2014-08-07

Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

#367

20140199709

2014-07-17

Methods for diagnosing irritable bowel syndrome

#368

20140178903

2014-06-26

Determination of levels of immunogenic gluten peptides in human samples

#369

20140178404

2014-06-26

Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis

#370

20140175018

2014-06-26

Diagnosing and treating inflammatory diseases

#371

20140161823

2014-06-12

Compositions and methods for diagnosing and treating an inflammation

#372

20140154690

2014-06-05

Device and method for non-invasive collection of colorectal mucocellular layer and disease detection

#373

20140141983

2014-05-22

Methods of disease activity profiling for personalized therapy management

#374

20140113873

2014-04-24

Method of increasing epithelial cell proliferation with chitin binding protein

#375

20130315990

2013-11-28

Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease

#376

20130303398

2013-11-14

Use and identification of biomarkers for gastrointestinal diseases

#377

20130259874

2013-10-03

Compositions and methods for diagnosing and treating an inflammation

#378

20130231293

2013-09-05

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

#379

20130131086

2013-05-23

Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues

#380

20130084292

2013-04-04

Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease

#381

20130059328

2013-03-07

Production of enteritis evoking causal factor by highly pathogenic oral bacteria and high sensitivity detection method therefor

#382

20130028910

2013-01-31

HMG1 antibody for treating inflammatory conditions

#383

20130022985

2013-01-24

EXAMINATION METHOD TO DETERMINE CONTRACTION OR ACTIVITY OF DISEASES RELATED IMMUNE SYSTEM OR JOINT SYSTEM

#384

20130022664

2013-01-24

LpfA antigen for prevention and treatment of infectious diseases

#385

20130012604

2013-01-10

METHODS OF USING PRDM1 GENETIC VARIANTS TO PROGNOSE, DIAGNOSE AND TREAT INFLAMMATORY BOWEL DISEASE

#386

20130005596

2013-01-03

NOVEL GENOMIC BIOMARKERS FOR IRRITABLE BOWEL SYNDROME DIAGNOSIS

#387

20120315630

2012-12-13

METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME

#388

20120309697

2012-12-06

METHODS OF DIAGNOSING AND PROGNOSING COLONIC POLYPS

#389

20120258477

2012-10-11

FECAL NEOPTERIN CONCENTRATION MEASUREMENT AS AN INDICATOR OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE

#390

20120244558

2012-09-27

Methods for diagnosing irritable bowel syndrome

#391

20120238468

2012-09-20

METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME

#392

20120213772

2012-08-23

Metabolic biomarkers of Crohn's Disease

#393

20120208214

2012-08-16

RAPID SACCHARIDE BIOMARKER ASSAY

#394

20120208212

2012-08-16

METHODS OF ASSESSING CROHN'S DISEASE PATIENT PHENOTYPE BY I2, OMPC AND ASCA SEROLOGIC RESPONSE

#395

20120207737

2012-08-16

MEDICAL UTILITY OF GLYCAN-BINDING PROTEINS AND GLYCANS

#396

20120196878

2012-08-02

METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERS

#397

20120195884

2012-08-02

Methods and products for evaluating an immune response to a therapeutic protein

#398

20120190571

2012-07-26

METHODS AND APPARATUS FOR DETECTION OF GLUTEN SENSITIVITY, AND ITS DIFFERENTIATION FROM CELIAC DISEASE

#399

20120186999

2012-07-26

ELECTROCHEMICAL SENSOR

#400

20120171704

2012-07-05

Elisa for a naturally-occurring soluble truncated form of IL-23 receptor

#401

20120171672

2012-07-05

INFLAMMATORY BOWEL DISEASE PROGNOSTICS

#402

20120171208

2012-07-05

Anti-PRO87299 Antibodies

#403

20120165220

2012-06-28

Uses of CD116 Expression Level

#404

20120135401

2012-05-31

Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease

#405

20120115746

2012-05-10

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING IRRITABLE BOWEL SYNDROME

#406

20120094289

2012-04-19

Materials and methods for determining cancer risk

#407

20120087902

2012-04-12

Therapeutic Use Of Probiotics

#408

20120082678

2012-04-05

GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF

#409

20120071422

2012-03-22

Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling

#410

20120059151

2012-03-08

Non-functional P2Xreceptor

#411

20120058497

2012-03-08

DIAGNOSTIC REAGENT FOR CROHN'S DISEASE

#412

20120058110

2012-03-08

Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment

#413

20120039924

2012-02-16

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

#414

20120027799

2012-02-02

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASE AND COLON CANCER

#415

20120015992

2012-01-19

Naphthalene-based inhibitors of anti-apoptotic proteins

#416

20120015867

2012-01-19

Therapeutic TREM-1 peptides

#417

20120004311

2012-01-05

Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

#418

20120003158

2012-01-05

Metabolite biomarkers to distinguish Crohn's disease from ulcerative colitis and methods using the same

#419

20110305704

2011-12-15

Antibody to cytolethal distending toxin of

#420

20110301053

2011-12-08

Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis

#421

20110287457

2011-11-24

Compositions and methods for diagnosing and treating an inflammation

#422

20110287030

2011-11-24

Compositions and methods for diagnosing and treating an inflammation

#423

20110251100

2011-10-13

Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders

#424

20110245107

2011-10-06

SELECTIVE DIFFERENTIATION, IDENTIFICATION, AMD MODULATION OF HUMAN TH17 CELLS

#425

20110230739

2011-09-22

Transcutaneous organ function measurement

#426

20110218956

2011-09-08

Methods of diagnosing inflammatory bowel disease

#427

20110212104

2011-09-01

INFLAMMATORY BOWEL DISEASE BIOMARKERS AND RELATED METHODS OF TREATMENT

#428

20110189685

2011-08-04

METHODS OF USING JAK3 GENETIC VARIANTS TO DIAGNOSE AND PREDICT CROHN'S DISEASE

#429

20110189198

2011-08-04

Compositions and methods for diagnosing and treating an inflammation

#430

20110183337

2011-07-28

Method and Kit for Use in the Differentiation of IBD and IBS and Further Distinction Between Disease Types of IBD

#431

20110177084

2011-07-21

Use application of sugar chain-recognizing receptor

#432

20110171232

2011-07-14

Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth

#433

20110159521

2011-06-30

Methods for diagnosing irritable bowel syndrome

#434

20110152117

2011-06-23

Methods of determining efficacy of treatments of diseases of the bowel

#435

20110136255

2011-06-09

COMPOSITION AND METHOD FOR PREDICTION OF COMPLICATED DISEASE COURSE IN CROHN'S DISEASE

#436

20110104170

2011-05-05

Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide

#437

20110092674

2011-04-21

Non-functional P2Xreceptor

#438

20110091980

2011-04-21

Diagnostic method for biomarkers of adverse coronary events

#439

20110081649

2011-04-07

DIAGNOSIS, STAGING AND MONITORING OF INFLAMMATORY BOWEL DISEASE

#440

20110055943

2011-03-03

NOVEL THERAPEUTIC TARGETS IN INFLAMMATORY BOWEL DISEASE

#441

20110045476

2011-02-24

Method for determining the risk of crohn's disease-related complications

#442

20110020952

2011-01-27

Method for determining the stage of ulcerative colitis or interstitial pneumonitis and reagent kit thereof

#443

20100317038

2010-12-16

Granzyme A and granzyme B diagnostics

#444

20100316992

2010-12-16

DIAGNOSTIC TEST

#445

20100311758

2010-12-09

METHOD FOR DIAGNOSIS OF INFLAMMATORY DISEASES USING CALGRANULIN C

#446

20100306863

2010-12-02

SCREENING, THERAPY AND DIAGNOSIS

#447

20100291566

2010-11-18

Systems and methods for diagnosis and monitoring of bacteria-related conditions

#448

20100267781

2010-10-21

Naphthalene-based inhibitors of anti-apoptotic proteins

#449

20100260861

2010-10-14

TREATMENTS WITH HELMINTHS

#450

20100255513

2010-10-07

SEROLOGICAL MARKERS OF INFLAMMATORY BOWEL DISEASE PHENOTYPE AND DISEASE PROGRESSION

#451

20100255508

2010-10-07

USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS

#452

20100254971

2010-10-07

Method for Diagnosing Prognosing Inflammatory Bowel Disease and Crohn's Disease

#453

20100242124

2010-09-23

Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same

#454

20100240077

2010-09-23

Methods of assessing Crohn's disease patient phenotype by I2 serologic response

#455

20100222228

2010-09-02

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING IRRITABLE BOWEL SYNDROME

#456

20100221746

2010-09-02

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

#457

20100210666

2010-08-19

METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY

#458

20100203556

2010-08-12

Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues

#459

20100196919

2010-08-05

PEPTIDES, ANTIBODIES AND FRAGMENTS THEREOF FOR THE TREATMENT AND DIAGNOSTIC OF CELIAC DISEASE

#460

20100196402

2010-08-05

Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody

#461

20100196318

2010-08-05

Methods of treating inflammatory and autoimmune diseases with natalizumab

#462

20100190162

2010-07-29

METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE

#463

20100184662

2010-07-22

Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis

#464

20100172905

2010-07-08

HMG1 antibody for treating inflammatory conditions

#465

20100151024

2010-06-17

Therapeutic agent for ulcerative colitis

#466

20100136550

2010-06-03

Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease

#467

20100129838

2010-05-27

METHODS FOR PREDICTION OF INFLAMMATORY BOWEL DISEASE (IBD) USING SEROLOGIC MARKERS

#468

20100105044

2010-04-29

Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease

#469

20100099124

2010-04-22

Method for Diagnosing Diseases Based on Levels of Anti-Glycan Antibodies

#470

20100094560

2010-04-15

METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME

#471

20100093552

2010-04-15

USE AND IDENTIFICATION OF BIOMARKERS FOR GASTROINTESTINAL DISEASES

#472

20100081129

2010-04-01

Genemap of the human genes associated with crohn's disease

#473

20100069256

2010-03-18

Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using a 20 Gene Panel

#474

20100062413

2010-03-11

METHOD OF EVALUATING IBD, AMINO ACID DATA PROCESSOR, AMINO ACID DATA-PROCESSING METHOD, AMINO ACID DATA-PROCESSING SYSTEM, AMINO-ACID DATA-PROCESSING PROGRAM AND RECORDING MEDIUM

#475

20100029692

2010-02-04

Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

#476

20100021455

2010-01-28

METHODS FOR DIAGNOSIS AND TREATMENT OF CROHN'S DISEASE

#477

20100015600

2010-01-21

Method for diagnosing and treating Crohn's disease

#478

20090325994

2009-12-31

Methods of treating diarrhea caused by small intestinal bacterial overgrowth

#479

20090325196

2009-12-31

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS

#480

20090312258

2009-12-17

USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES

#481

20090312257

2009-12-17

USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES

#482

20090312256

2009-12-17

USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES

#483

20090311261

2009-12-17

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#484

20090311260

2009-12-17

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#485

20090305267

2009-12-10

MICROBIAL MARKERS OF INFLAMMATORY BOWEL DISEASE

#486

20090275738

2009-11-05

Use of A33 antigens and JAM-IT

#487

20090263916

2009-10-22

Antagonists of HMG1 for treating inflammatory conditions

#488

20090253632

2009-10-08

Therapeutic peptides and method

#489

20090253155

2009-10-08

Method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel disease

#490

20090253153

2009-10-08

Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY

#491

20090226460

2009-09-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

#492

20090202517

2009-08-13

AGENTS FOR IMPROVING INFLAMMATORY BOWEL DISEASE

#493

20090202474

2009-08-13

EXPRESSION OF ORPHAN GPR64 IN INFLAMMATORY DISEASES

#494

20090197806

2009-08-06

Adiponectin for treatment of various disorders

#495

20090192293

2009-07-30

Non-functional P2Xreceptor

#496

20090186371

2009-07-23

Method for determination of inflammatory bowel disease

#497

20090181024

2009-07-16

NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#498

20090176256

2009-07-09

Methods and products for evaluating an immune response to a therapeutic protein

#499

20090176244

2009-07-09

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF CROHN'S DISEASE

#500

20090175855

2009-07-09

NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#501

20090170115

2009-07-02

Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease

#502

20090162348

2009-06-25

Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof

#503

20090142778

2009-06-04

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

#504

20090130775

2009-05-21

Method for determining the stage of ulcerative colitis or interstitial pneumonitis and reagent kit thereof

#505

20090111131

2009-04-30

Method of detecting protein losing enteropathy in animals

#506

20090081229

2009-03-26

ANTI-PRO87299 ANTIBODIES

#507

20090022713

2009-01-22

Anti-PRO87299 antibodies

#508

20090012113

2009-01-08

Methods of treating a subject suffering from irritable bowel syndrome

#509

20080317666

2008-12-25

Colonic Delivery of Active Agents

#510

20080312421

2008-12-18

Use of A33 antigens and JAM-it

#511

20080293625

2008-11-27

Diagnosis of Inflammatory Bowel Diseases, More Particularly Ulcerative Colitis

#512

20080280367

2008-11-13

Modulators Of NOD2 Signalling

#513

20080206261

2008-08-28

METHODS FOR SCREENING, TREATING AND DIAGNOSING INFLAMMATORY BOWEL DISEASE AND COMPOSITIONS THEREOF

#514

20080193945

2008-08-14

Method and Kit for the Diagnosis of Ulcerative Colitis

#515

20080182291

2008-07-31

Diagnosis of constipation by analysis of methane concentration

#516

20080182280

2008-07-31

METHODS OF DIAGNOSING INFLAMMATORY BOWEL DISEASE

#517

20080171344

2008-07-17

Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase

#518

20080166750

2008-07-10

Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

#519

20080166719

2008-07-10

Methods for diagnosing irritable bowel syndrome

#520

20080152653

2008-06-26

Anti-α9 integrin antibody and the use thereof

#521

20080131439

2008-06-05

Methods of diagnosing inflammatory bowel disease

#522

20080131438

2008-06-05

Antibodies to non-functional P2Xreceptor

#523

20080089881

2008-04-17

Treatment and Diagnostics of Inflammatory Diseases

#524

20080085524

2008-04-10

METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME

#525

20080064111

2008-03-13

Methods for diagnosing a gastrointestinal disorder in an individual

#526

20080019909

2008-01-24

Modulation of Programmed Necrosis

#527

20080014185

2008-01-17

Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth

#528

20080014184

2008-01-17

Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth

#529

20080010691

2008-01-10

Method of Screening Therapeutic Agent for Irritable Bowel Syndrome

#530

20080009439

2008-01-10

Compositions and Methods of Use for a Fibroblast Growth Factor

#531

20070275424

2007-11-29

Diagnostic Tests and Methods for Diagnosing Inflammatory Bowel Disease

#532

20070264662

2007-11-15

Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3

#533

20070248605

2007-10-25

Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention

#534

20070212353

2007-09-13

Therapeutic target and diagnostic marker for asthma and related conditions

#535

20070207141

2007-09-06

Methods of treating inflammatory and autoimmune diseases with natalizumab

#536

20070197554

2007-08-23

Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

#537

20070197461

2007-08-23

Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

#538

20070196931

2007-08-23

Therapeutic agent for ulcerative colitis

#539

20070190049

2007-08-16

Use of A33 antigens and JAM-IT

#540

20070184554

2007-08-09

Biomarker of improved intestinal function

#541

20070161061

2007-07-12

PRO87299 polypeptides

#542

20070092912

2007-04-26

USES OF HUMAN ZVEN ANTAGONISTS

#543

20070087983

2007-04-19

Novel ubp8rp polypeptides and their use in the treatment of psoriasis

#544

20070087440

2007-04-19

Rapid serum sugar biomarker assay of rheumatoid arthritis

#545

20070087414

2007-04-19

Isolated nucleic acid sequence comprising SEQ ID NO: 14 and methods of using said nucleic acid sequence

#546

20070078259

2007-04-05

Uses of human Zven proteins and polynucleotides

#547

20070065405

2007-03-22

Uses of human Zven proteins and polynucleotides

#548

20070065404

2007-03-22

Uses of humans zven proteins and polynucleotides

#549

20070065403

2007-03-22

Uses of human Zven proteins and polynucleotides

#550

20070053908

2007-03-08

USES OF HUMAN ZVEN ANTAGONISTS

#551

20070053907

2007-03-08

USES OF HUMAN ZVEN ANTAGONISTS

#552

20070049526

2007-03-01

Methods of modulating gastrointestinal contractility

#553

20070048778

2007-03-01

Methods of detecting or diagnosing inflammatory bowel disease using prokineticin polynucleotides

#554

20070048258

2007-03-01

Use of human Zven proteins and polynucleotides

#555

20070031405

2007-02-08

Use of A33 antigens and jam-it

#556

20070025991

2007-02-01

Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation

#557

20060286119

2006-12-21

Compositions and methods for treatment of chronic and infectious diseases

#558

20060286112

2006-12-21

Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders

#559

20060275317

2006-12-07

Vaccine compositions for prevention of chronic and infectious diseases

#560

20060275289

2006-12-07

Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient

#561

20060270835

2006-11-30

Diagnosis and treatment of Alzheimer disease

#562

20060269981

2006-11-30

Diagnostic kit for hirschsprung disease (Congenital Megacolon)

#563

20060269976

2006-11-30

METHOD FOR REDUCING LYSOZYME ENZYMATIC ACTIVITY

#564

20060251659

2006-11-09

Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity

#565

20060240019

2006-10-26

Antagonists of HMG1 for treating inflammatory conditions

#566

20060233803

2006-10-19

Use of A33 antigens and JAM-it

#567

20060226029

2006-10-12

Measuring apparatus for ulcerative colitis diagnosis/prognostic test and method of measuring

#568

20060216726

2006-09-28

Method for optimizing thiopurine efficacy and toxicity using mass spectrometry

#569

20060216716

2006-09-28

Immunologic activity measures for t helper on-associated conditions

#570

20060211604

2006-09-21

Methods for treating inflammatory disorders using regulators of microvessel dilations

#571

20060210565

2006-09-21

Methods of diagnosing sepsis by measuring HMG1

#572

20060205084

2006-09-14

Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

#573

20060205022

2006-09-14

Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease

#574

20060205014

2006-09-14

Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease

#575

20060205012

2006-09-14

Diagnostic test

#576

20060160118

2006-07-20

Modulators of Nod2 signaling

#577

20060154276

2006-07-13

Methods of diagnosing inflammatory bowel disease

#578

20060141500

2006-06-29

Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease

#579

20060105381

2006-05-18

Polymorphisms of the OCTN1 cation transporters associated with inflammatory bowel disorders

#580

20060100132

2006-05-11

Method for diagnosing inflammatory bowel disease

#581

20060083686

2006-04-20

Therapeutic agent for ulcerative colitis

#582

20060063149

2006-03-23

Compositions and methods for detecting pathogen infection

#583

20060035834

2006-02-16

Compositions and methods for diagnosing and treating an inflammation

#584

20060029550

2006-02-09

Methods of treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth

#585

20060003392

2006-01-05

Methods of diagnosing inflammatory bowel disease

#586

20050277181

2005-12-15

Compositions and kits for detecting pathogen infection

#587

20050272118

2005-12-08

Anti-PRO87299 antibodies

#588

20050234078

2005-10-20

Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

#589

20050147972

2005-07-07

Method of diagnosis of inflammatory diseases using calgranulin c

#590

20050142618

2005-06-30

Method for diagnosing diseases based on levels of anti-glycan antibodies

#591

20050130189

2005-06-16

Method of treating irritable bowel syndrome

#592

20050124006

2005-06-09

Method for diagnosing diseases based on levels of anti-glycan antibodies

#593

20050089957

2005-04-28

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#594

20050084910

2005-04-21

Method for measuring FceRII/CD23 IgE receptor in human feces as an indicator of a TH2 predominant immune response involved in gastrointestinal illnesses

#595

20050074818

2005-04-07

Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease

#596

20050054021

2005-03-10

Methods of assessing Crohn's disease patient phenotype by I2, OmpC and ASCA serologic response

#597

20050008652

2005-01-13

Method of diagnosing fibromyalgia caused by small intestinal bacterial overgrowth

#598

15601509

2019-10-29

Methods for determining clinical response to TNF-alpha and/or JAK inhibitors in subjects with inflammatory diseases